Home
Live Updates
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding : comparemela.com
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding
BOSTON, May 18, 2022 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration with the National
Related Keywords
Boston ,
Massachusetts ,
United States ,
Prnewswire Postera ,
Kostenloser Wertpapierhandel ,
Alpha Lee ,
Infectious Diseases Antiviral Program For Pandemics ,
National Institutes Of Health ,
Drugs For Neglected Diseases Initiative ,
Antiviral Program For Pandemics ,
Memorial Sloan Kettering Cancer Center ,
National Institutes ,
Neglected Diseases Initiative ,
Memorial Sloan Kettering Cancer ,
National Institute ,
Infectious Diseases Antiviral Program ,
Structure Enabled Antiviral Platform ,
Chief Scientific Officer ,
Antiviral Drug Discovery ,
Antiviral Program ,
Postera ,
Spearheads ,
Riven ,
Drug ,
Discovery ,
Collaboration ,
Evelop ,
Antiviral ,
Herapeutics ,
Nitial ,
Funding ,
comparemela.com © 2020. All Rights Reserved.